LOXL2 and uterine corpus endometrial carcinoma: Despite the wealth of information available on the overexpression of LOXL2 in tumors, there are scarce data regarding the presence of genetic mutations in LOXL2. Mutations in LOXL2 are identified in skin cutaneous melanoma and uterine corpus endometrial carcinoma.